| (210) | Number of the EPO application | 16754148 |
| (220) | Filing date of the EPO application | 2016.08.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 23/2020, 2020.06.03 |
| (110) | EPO patent number | 3337824 |
| (21) | Number of the application | e 2018 0628 |
| (71) | Name(s) of applicant(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (72) | Name(s) of inventor(s), code of the country | PILLARISETTI Kodandaram, US;
BALDWIN Eric Thomas, US;
POWERS Gordon D., US;
CARDOSO Rosa Maria Fernandes, US;
ATTAR Ricardo, US;
GAUDET Francois, US; |
| (73) | Name(s) of owner(s), code of the country | JANSSEN PHARMACEUTICA NV, BE; |
| (54) | Title of the invention | ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01) |
| (19) | Country | BE |
| (41) | Date of publication of the application | 2018.08.31 |
| (30) | Priority | 201562206246 P, 2015.08.17, US |
| (86) | International application | PCT/US2016/047146, 2016.08.16 |
| (87) | International publication | WO 2017/031104, 2017.02.23 |